• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析青春期后期前住院肥胖儿童非酒精性脂肪肝的危险因素。

Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage.

机构信息

Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Wuhan Wuchang Hospital, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan University of Science and Technology, Wuhan, Hubei, China.

出版信息

Front Endocrinol (Lausanne). 2023 Aug 31;14:1224816. doi: 10.3389/fendo.2023.1224816. eCollection 2023.

DOI:10.3389/fendo.2023.1224816
PMID:37720532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10501779/
Abstract

OBJECTIVE

This study aimed to determine the clinical characteristics of obese pediatric non-alcoholic fatty liver disease (NAFLD) in central China and verify the applicability of some known risk factors for pediatric NAFLD before late puberty.

METHODS

This was a retrospective case-control study. A total of 1,029 inpatients at Wuhan Children's Hospital before the late puberty stage were enrolled in the study, including 815 children with obesity (non-NAFLD group) and 214 children with obesity and NAFLD (NAFLD group) diagnosed by liver ultrasound. Subgroup analyses were performed according to sex and puberty. The anthropometric indices and laboratory test data of these 1,029 children were sorted. After intergroup comparison, a logistic regression model was used to determine the risk factors for pediatric NAFLD. Significant risk factors for NAFLD were further tested using receiver operating characteristic (ROC) curves to evaluate their ability to predict an early diagnosis of NAFLD.

RESULTS

The NAFLD group had a mean age of 11.03 ± 1.66, with 11.18 ± 1.66 and 10.27 ± 1.45 years for male and female children, respectively ( < 0.05 and < 0.01, respectively). Even subdivided by both sex and puberty, raised body mass index (BMI), homeostatic model-insulin resistance, triglycerides, alanine transaminase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (γ-GT) were still found in the non-NAFLD and NAFLD groups ( < 0.05 and < 0.01, respectively). The results of logistic regression analysis showed that BMI (odds ratio [OR], 1.468;95% confidence interval [CI], 1.356-1.590; <0.001) and ALT (OR, 1.073;95%CI, 1.060-1.087; <0.001) were two most independent risk factors for NAFLD. The maximal OR for BMI was 1.721 (95% CI, 1.336-2.217). In the female group, the maximal OR of ALT was found to be 1.104 (95% CI, 1.061-1.148). Age and thyroid-stimulating hormone (TSH) and γ-GT levels were also risk factors, but they appeared only in some groups. The results of the ROC analysis showed that ALT was a better predictor of pediatric NAFLD than BMI. The maximum area under the ROC curve in six of the nine groups belongs to ALT.

CONCLUSIONS

BMI, ALT, and age are risk factors for NAFLD in children with obesity before late puberty. BMI had the greatest exposure risk for NAFLD, and ALT had the highest predictive value for the diagnosis of NAFLD. At the stratified level, for exposure risk, age was specific to the male sex, TSH was specific to the early puberty stage, and γ-GT was specific to the female sex plus the prepuberty stage. On a stratified level, for the female sex, even with age stratification, BMI rather than ALT has a better ability for the diagnosis of NAFLD.

摘要

目的

本研究旨在确定中国中部肥胖儿童非酒精性脂肪性肝病(NAFLD)的临床特征,并验证一些已知的儿科 NAFLD 风险因素在青春期后期之前的适用性。

方法

这是一项回顾性病例对照研究。共纳入武汉儿童医院青春期前的 1029 例住院患儿,包括 815 例肥胖患儿(非 NAFLD 组)和 214 例肥胖伴 NAFLD 患儿(NAFLD 组),由肝脏超声诊断。根据性别和青春期进行亚组分析。对这 1029 例患儿的人体测量学指标和实验室检查数据进行排序。在组间比较后,采用 logistic 回归模型确定儿科 NAFLD 的危险因素。使用受试者工作特征(ROC)曲线进一步检验有意义的 NAFLD 危险因素,以评估其对早期诊断 NAFLD 的能力。

结果

NAFLD 组的平均年龄为 11.03±1.66 岁,男性和女性儿童的平均年龄分别为 11.18±1.66 岁和 10.27±1.45 岁(<0.05 和 <0.01)。即使按照性别和青春期进行细分,非 NAFLD 和 NAFLD 组仍存在升高的体重指数(BMI)、稳态模型胰岛素抵抗、甘油三酯、丙氨酸转氨酶(ALT)、天门冬氨酸转氨酶(AST)和γ-谷氨酰转移酶(γ-GT)(<0.05 和 <0.01)。logistic 回归分析结果显示,BMI(比值比[OR],1.468;95%置信区间[CI],1.356-1.590;<0.001)和 ALT(OR,1.073;95%CI,1.060-1.087;<0.001)是 NAFLD 的两个最独立的危险因素。BMI 的最大 OR 为 1.721(95%CI,1.336-2.217)。在女性组中,ALT 的最大 OR 为 1.104(95%CI,1.061-1.148)。年龄和促甲状腺激素(TSH)和 γ-GT 水平也是危险因素,但它们仅出现在某些组中。ROC 分析结果表明,ALT 是预测儿科 NAFLD 的较好指标,在 9 组中有 6 组的 ROC 曲线下面积最大的属于 ALT。

结论

在青春期前肥胖儿童中,BMI、ALT 和年龄是非酒精性脂肪性肝病的危险因素。BMI 对 NAFLD 的暴露风险最大,ALT 对 NAFLD 的诊断预测价值最高。在分层水平上,对于暴露风险,年龄对男性具有特异性,TSH 对早期青春期具有特异性,γ-GT 对女性加青春期前具有特异性。在分层水平上,对于女性,即使进行年龄分层,BMI 而不是 ALT 对 NAFLD 的诊断能力更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf82/10501779/a5718cb7f4e9/fendo-14-1224816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf82/10501779/57c1a90a38f9/fendo-14-1224816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf82/10501779/a5718cb7f4e9/fendo-14-1224816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf82/10501779/57c1a90a38f9/fendo-14-1224816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf82/10501779/a5718cb7f4e9/fendo-14-1224816-g002.jpg

相似文献

1
Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage.分析青春期后期前住院肥胖儿童非酒精性脂肪肝的危险因素。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1224816. doi: 10.3389/fendo.2023.1224816. eCollection 2023.
2
The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.新提出的丙氨酸氨基转移酶与高密度脂蛋白胆固醇比值在识别非酒精性脂肪性肝病方面显示出有效性。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1239398. doi: 10.3389/fendo.2023.1239398. eCollection 2023.
3
Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与中国儿童和青少年非酒精性脂肪肝的相关性:一项大型单中心横断面研究。
Lipids Health Dis. 2020 Nov 22;19(1):242. doi: 10.1186/s12944-020-01421-5.
4
Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents.评估胰岛素抵抗和脂质相关指标预测肥胖青少年非酒精性脂肪性肝病(NAFLD)的能力。
Lipids Health Dis. 2024 Jul 2;23(1):208. doi: 10.1186/s12944-024-02144-7.
5
Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.非肥胖人群中非酒精性脂肪性肝病的临床特征。
Obes Facts. 2023;16(5):427-434. doi: 10.1159/000530845. Epub 2023 May 22.
6
Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.脂联素-瘦素比值可早期发现非肥胖型非酒精性脂肪性肝病,与胰岛素抵抗无关。
Ann Med. 2023 Dec;55(1):634-642. doi: 10.1080/07853890.2023.2179106.
7
Association of whole blood copper, zinc, calcium, magnesium, and iron with non-alcoholic fatty liver disease in overweight and obese children.全血铜、锌、钙、镁、铁与超重肥胖儿童非酒精性脂肪肝病的关系。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 28;49(3):426-434. doi: 10.11817/j.issn.1672-7347.2024.230274.
8
Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.肥胖儿童中非酒精性脂肪性肝病(NAFLD)的预测因素
J Pediatr Endocrinol Metab. 2020 Feb 25;33(2):247-253. doi: 10.1515/jpem-2019-0403.
9
Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.酒精性肝病(ALD)/非酒精性脂肪性肝病(NAFLD)指数联合γ-谷氨酰转移酶在鉴别ALD和NAFLD中的诊断价值。
Korean J Intern Med. 2016 May;31(3):479-87. doi: 10.3904/kjim.2015.253. Epub 2016 Mar 30.
10
Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States.ALT/AST 比值升高作为非酒精性脂肪性肝病风险和严重程度的标志物:来自美国横断面分析的见解。
Front Endocrinol (Lausanne). 2024 Aug 26;15:1457598. doi: 10.3389/fendo.2024.1457598. eCollection 2024.

引用本文的文献

1
[Meta analysis of the prevalence and risk factors of non-alcoholic fatty liver disease in overweight and obese children and adolescents in China].[中国超重和肥胖儿童青少年非酒精性脂肪性肝病患病率及危险因素的Meta分析]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Apr 15;27(4):410-419. doi: 10.7499/j.issn.1008-8830.2408148.
2
Web of Science-Based Visualization of Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric and Adolescent Populations: A Bibliometric Study.基于科学网的儿童和青少年人群中代谢功能障碍相关脂肪性肝病的可视化分析:一项文献计量学研究
Health Sci Rep. 2025 Jan 29;8(2):e70409. doi: 10.1002/hsr2.70409. eCollection 2025 Feb.
3

本文引用的文献

1
Nonalcoholic fatty liver disease in children with obesity- observations from one clinical centre in the Western Pomerania region.儿童肥胖症相关非酒精性脂肪肝疾病-来自西波美拉尼亚地区某一临床中心的观察结果。
Front Endocrinol (Lausanne). 2022 Oct 31;13:992264. doi: 10.3389/fendo.2022.992264. eCollection 2022.
2
Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.儿童肥胖相关非酒精性脂肪性肝病的临床谱转换及预测模型。
Front Endocrinol (Lausanne). 2022 Aug 31;13:986841. doi: 10.3389/fendo.2022.986841. eCollection 2022.
3
It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?
Analysis of risk factors for fatty liver disease in children with Wilson's disease.
分析 Wilson 病儿童脂肪肝的危险因素。
Eur J Gastroenterol Hepatol. 2024 Aug 1;36(8):1046-1053. doi: 10.1097/MEG.0000000000002801. Epub 2024 Jun 10.
是时候让医生考虑用天然产物来缓解非酒精性脂肪性肝病了。有足够的证据可以使用它们吗?
Int J Mol Sci. 2021 Dec 14;22(24):13424. doi: 10.3390/ijms222413424.
4
Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: A nationwide nested case-control study.儿童肥胖症中非酒精性脂肪肝的风险和保护因素:一项全国性巢式病例对照研究。
Clin Obes. 2022 Apr;12(2):e12502. doi: 10.1111/cob.12502. Epub 2021 Dec 6.
5
[Survey of height and weight of children and adolescents at different Tanner stages in urban China].中国城市不同坦纳阶段儿童及青少年身高体重调查
Zhonghua Er Ke Za Zhi. 2021 Dec 2;59(12):1065-1073. doi: 10.3760/cma.j.cn112140-20210525-00453.
6
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis.评估超重或肥胖儿童和青少年代谢功能障碍相关脂肪性肝病的全球患病率:系统评价和荟萃分析。
Int J Public Health. 2021 Oct 6;66:1604371. doi: 10.3389/ijph.2021.1604371. eCollection 2021.
7
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function.格列净类药物对心血管的益处:对内皮功能的影响。
Biomedicines. 2021 Sep 29;9(10):1356. doi: 10.3390/biomedicines9101356.
8
Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps.儿童肥胖相关非酒精性脂肪性肝病:叙述性综述和研究空白。
Horm Res Paediatr. 2022;95(2):167-176. doi: 10.1159/000518595. Epub 2021 Jul 21.
9
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.中华医学会肝病学分会关于脂肪肝疾病重新定义的立场声明。
J Hepatol. 2021 Aug;75(2):454-461. doi: 10.1016/j.jhep.2021.05.003. Epub 2021 May 19.
10
Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.肥胖伴胰岛素抵抗和 2 型糖尿病青少年的非酒精性脂肪性肝病。
Front Endocrinol (Lausanne). 2021 Apr 6;12:639548. doi: 10.3389/fendo.2021.639548. eCollection 2021.